Sign In
Product
has been added to your cart.
California Workers’ Compensation Institute
Research
Research Reports
Claim Characteristics and Trends Interactive Application
Interactive Research Applications
Independent Medical Review
Regulatory
RegTracker
Regulations
Regulations by Category
Medical Fee Schedule
Legal
Legal Brief Bank
Communications
Overview
Executive Briefings
Quarterly Summaries
Technical Issues
Bulletins
News
Committee Activity
Board of Directors
Executive Committee Schedule
Claims Committee Schedule
FAQ
Employers
Employees
Physicians
External Resources
Shop
Store
Seminars
Subscriptions
About
What We Do
Our Staff
CWCI Members
Mission Statement
Events
MTUS Drug Formulary
Show All
Drug List Updates Adopted by AD Order - Effective August 6, 2025
08/06/2025
Newsline 2025-63:
AD Statement:
MTUS Drug List v 13 Addendum 1:
MTUS Drug List v 13 Addendum 2:
MTUS Drug List v 13 Addendum 1 and 2:
Drug List Updates Adopted by AD Order - Effective November 1, 2024
11/07/2024
DIR Newsline 2024-82:
AD Statement:
MTUS Drug List v. 12 Addendum 1:
MTUS Drug List v 12 Addendum 2:
Drug List v 12 Addendum 1 & 2:
Drug List Updates Adopted by AD Order - Effective February 15, 2024
02/15/2024
DIR Newsline 2024-12:
AD Statement Revised:
Drug List v.11.1 Addendum 1:
Drug List v.11.1 Addendum 2:
Drug List v.11.1 Addendums 1 & 2:
DIR Newsline 2024-05:
AD Statement:
Drug List v. 11 Addendum 1:
Drug List v. 11 Addendum 2:
Drug List v. 11 Addendums 1 & 2:
Drug List Updates Adopted by AD Order - Effective November 1, 2022
11/01/2022
DWC Newsline 2022-75:
AD Order:
Drug List v. 10 - Addendum 1:
Drug List v.10 - Addendum 2:
Drug List v.10 - Addendums 1 & 2:
Drug List Updates Adopted by AD Order - Effective August 1, 2021
08/01/2021
DWC Newsline 2021-70:
AD Order:
Drug List v. 9 - Addendum 1:
Drug List v. 9 - Addendum 2:
Drug List v. 9 - Addendums 1 & 2:
Drug List Updates Adopted by AD - Effective February 1, 2021
02/01/2021
DWC Newsline 2020-107:
AD Order:
Drug List v.8 - Addendums 1 & 2:
Drug List v.8 - Addendum 2:
Drug List v.8 - Addendum 1:
Drug List Updates Adopted by AD Order - effective November 1, 2020
11/01/2020
DWC Newsline - 2020-84:
AD Order:
Drug List v.7 - Addendum 1:
Drug List v.7 - Addendum 2 - Strikethrough:
Drug List v.7 - Addendums 1 & 2:
Drug List Updates Adopted by AD Order - effective January 15, 2020
01/15/2020
DWC Newsline 2019-96:
AD Order:
Drug List v6 - Addendum 1 (clean):
Drug List v6 - Addendum 2 (highlighted changes):
Drug List v6 - Addendum 1 & 2:
Drug List Updates Adopted by AD Order - effective August 1, 2019
08/01/2019
DWC Newsline 2019-59:
AD Order:
Drug List v5 - Addendum 1 (clean):
Drug List v5 - Addendum 2 (highlighted changes):
Drug List v5 - Addendum 1 & 2:
Drug List Updates Adopted by AD Order - effective February 15, 2019
02/15/2019
DWC Newsline 2019-04:
AD Order:
Drug List v4 - Addendum 1 (clean):
Drug List v4 - Addendum 2 (highlighted changes):
Drug List v4 - Addendum 1 & 2:
Drug List Updates Adopted by AD Order - effective October 1, 2018
09/06/2018
DWC Newsline 2018 -70:
AD Order:
Drug List v3 - (clean version):
Drug List v3 - (underlined):
Drug List Updates Adopted by AD Order - Effective 5/15/18
04/17/2018
DWC Newsline 2018-31:
AD Order:
MTUS Drug List - Addendum 1 clean:
MTUS Drug List - (changes) Addendum 2:
MTUS Drug List - Addendum 1 & 2:
Approved by OAL and Filed w Secretary of State - effective 1/1/2018
12/08/2017
DWC Newsline 2017-115 :
Regulations:
MTUS Drug List:
P&T Committee Conflict of Interest Disclosure Form:
P&T Committee Application:
2nd 15-day comment chart:
15-day comment chart:
45-day comment chart:
Final Statement of Reasons - Addendum:
Final Statement of Reasons:
Submitted to OAL; Deadline = 12/7/17
12/07/2017
FSOR:
Regulations:
P&T Forms (Application & COI):
Drug List:
2nd 15 Day Comments & Responses :
1st 15 Day Comments & Responses:
45 Day Comments & Responses:
2nd 15-Day Public Comment Period
09/22/2017
CWCI comment:
Notice of modification to text of proposed regulations:
Text of proposed regulations:
Proposed MTUS Drug List [Excerpt " proposed modifications on first page only] :
DWC Newsline 2017-82:
1st 15-Day Public Comment Period
08/02/2017
CWCI 15-Day Comments:
DWC Newsline 2017-61:
Notice of Modification of Proposed Regs:
MTUS Drug List - MODIFIED:
Regulations:
45-Day Public Testimony
05/01/2017
CWCI written testimony:
DWC Newsline 2017-20:
Fiscal Impact Statement:
Initial Statement of Reasons:
Notice of Proposed Rulemaking:
P&T Committee Application:
P&T Committee Conflict of Interest Disclosure Form:
Proposed MTUS Drug List:
Regulation:
Related Documents
No related documents found.
Menu